Fluidigm Corporation (FLDM) Shares Sold by Neuberger Berman Group LLC

Neuberger Berman Group LLC cut its position in Fluidigm Corporation (NASDAQ:FLDM) by 3.8% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,851,381 shares of the medical research company’s stock after selling 73,027 shares during the quarter. Neuberger Berman Group LLC owned approximately 6.32% of Fluidigm Corporation worth $7,480,000 at the end of the most recent reporting period.

Other large investors have also recently bought and sold shares of the company. Wells Fargo & Company MN grew its stake in Fluidigm Corporation by 15.0% in the 1st quarter. Wells Fargo & Company MN now owns 25,521 shares of the medical research company’s stock valued at $146,000 after buying an additional 3,327 shares during the last quarter. Bank of New York Mellon Corp grew its position in Fluidigm Corporation by 20.5% in the 1st quarter. Bank of New York Mellon Corp now owns 206,578 shares of the medical research company’s stock worth $1,175,000 after purchasing an additional 35,176 shares during the last quarter. Paloma Partners Management Co grew its position in Fluidigm Corporation by 319.4% in the 1st quarter. Paloma Partners Management Co now owns 125,000 shares of the medical research company’s stock worth $711,000 after purchasing an additional 95,193 shares during the last quarter. Wellington Management Group LLP grew its position in Fluidigm Corporation by 2.4% in the 1st quarter. Wellington Management Group LLP now owns 630,277 shares of the medical research company’s stock worth $3,587,000 after purchasing an additional 14,814 shares during the last quarter. Finally, American International Group Inc. grew its position in Fluidigm Corporation by 7.1% in the 1st quarter. American International Group Inc. now owns 17,907 shares of the medical research company’s stock worth $102,000 after purchasing an additional 1,187 shares during the last quarter. Institutional investors and hedge funds own 88.90% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: This piece of content was posted by Sports Perspectives and is owned by of Sports Perspectives. If you are accessing this piece of content on another publication, it was illegally stolen and republished in violation of United States & international trademark & copyright law. The correct version of this piece of content can be viewed at https://sportsperspectives.com/2017/09/11/fluidigm-corporation-fldm-shares-sold-by-neuberger-berman-group-llc.html.

Fluidigm Corporation (FLDM) opened at 5.33 on Monday. The firm’s market cap is $156.78 million. The company’s 50-day moving average is $3.86 and its 200-day moving average is $4.66. Fluidigm Corporation has a one year low of $2.52 and a one year high of $8.82.

Fluidigm Corporation (NASDAQ:FLDM) last released its earnings results on Thursday, August 3rd. The medical research company reported ($0.58) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.60) by $0.02. The business had revenue of $23.90 million during the quarter, compared to the consensus estimate of $23.50 million. Fluidigm Corporation had a negative net margin of 74.05% and a negative return on equity of 121.04%. The company’s revenue for the quarter was down 15.2% compared to the same quarter last year. During the same quarter in the prior year, the firm posted ($0.63) EPS. On average, analysts forecast that Fluidigm Corporation will post ($2.13) earnings per share for the current fiscal year.

In other news, insider Steven Mcphail bought 20,000 shares of the firm’s stock in a transaction on Tuesday, August 8th. The stock was acquired at an average price of $3.00 per share, with a total value of $60,000.00. Following the transaction, the insider now owns 27,842 shares of the company’s stock, valued at approximately $83,526. The acquisition was disclosed in a document filed with the SEC, which is available through this link. Also, insider Levin Capital Strategies, L.P. bought 4,003,129 shares of the firm’s stock in a transaction on Thursday, August 10th. The shares were purchased at an average cost of $3.30 per share, with a total value of $13,210,325.70. The disclosure for this purchase can be found here. Insiders have acquired a total of 4,106,038 shares of company stock valued at $13,496,083 in the last three months. Insiders own 4.70% of the company’s stock.

A number of equities analysts have recently commented on FLDM shares. Zacks Investment Research raised shares of Fluidigm Corporation from a “sell” rating to a “hold” rating in a report on Thursday, June 1st. ValuEngine downgraded shares of Fluidigm Corporation from a “sell” rating to a “strong sell” rating in a report on Friday, June 2nd.

Fluidigm Corporation Company Profile

Fluidigm Corporation creates, manufactures and markets technologies and life science tools focused on the exploration and analysis of single cells, as well as the industrial application of genomics, based upon the Company’s core microfluidics and mass cytometry technologies. The Company operates in the development, manufacturing and commercialization of life science tools for the life science and Ag-Bio industries segment.

Want to see what other hedge funds are holding FLDM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Fluidigm Corporation (NASDAQ:FLDM).

Institutional Ownership by Quarter for Fluidigm Corporation (NASDAQ:FLDM)

Receive News & Ratings for Fluidigm Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fluidigm Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply